Hyperglycemia in mothers with GDM is a teratogenic condition that affects organogenesis and induce epigenetic changes primarily through insulin production, modifications Melanocortin 4 receptor, lipoprotein lipase, and leptin methylation patterns, and increased adiposity in the growing fetus [12–15]. This evidence concerns the gene LPL and Hyperglycemia.